The total synthesis of a bisanthraquinone natural product provides the opportunity to investigate the medicinal properties of a new class of antibiotics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nicolaou, K. C., Lin, Y. H. & Becker, J. Angew. Chem. Int. Ed. doi:10.1002/anie.200900058 (2009).
Bentley, S. D. et al. Nature 417, 141–147 (2002).
Ikeda, H. et al. Nature Biotechnol. 21, 526–531 (2003).
Fenical, W. & Jensen, P. R. Nature Chem. Biol. 2, 666–673 (2006).
Corey, E. J. et al. J. Am. Chem. Soc. 100, 4620–4622 (1978).
Newman, D. J. & Cragg, G. M. J. Nat. Prod. 70, 461–477 (2007).
Kushida, H. et al. Antitumoric BE43472 manufacture with Strptomyces. JPO patent 8,143,569 (1996).
Socha, A. M. et al. J. Nat. Prod. 69, 1070–1073 (2006).
Socha, A. M. et al. Bioorg. Med. Chem. 14, 8446–8454 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rowley, D. A cascade of new antibiotics. Nature Chem 1, 110–112 (2009). https://doi.org/10.1038/nchem.192
Issue Date:
DOI: https://doi.org/10.1038/nchem.192
